Bulletin
Investor Alert

May 4, 2020, 4:44 p.m. EDT

CymaBay Therapeutics to Report First Quarter 2020 Financial Results on Monday, May 11

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    CymaBay Therapeutics Inc. (CBAY)

or Cancel Already have a watchlist? Log In

NEWARK, May 04, 2020 (GLOBE NEWSWIRE via COMTEX) -- CymaBay Therapeutics, Inc. /zigman2/quotes/201917619/composite CBAY +0.30% , a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet need, today announced that it will host a conference call and live audio webcast on Monday, May 11, 2020 at 4:30 p.m. Eastern Time to discuss financial results for the first quarter ended March 31, 2020 and to provide a business update.

Conference Call Details

To access the live conference call, please dial 855-327-6837 from the U.S. and Canada, or 631-891-4304 internationally, Conference ID# 10009543. To access the live and subsequently archived webcast of the conference call, go to the Investors section of the company's website at http://ir.cymabay.com/events .

About CymaBay

CymaBay Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet medical need.

For additional information about CymaBay visit www.cymabay.com .

Contact:

Sloane & Company

Dan Zacchei / Joe Germani, 212-486-9500

Dzacchei@sloanepr.com / JGermani@sloanepr.com

https://ml.globenewswire.com/media/4ae714bc-fc58-4a8c-94eb-53e0b0c13a01/small/cbay-logo-jpg.jpg

(C) Copyright 2020 GlobeNewswire, Inc. All rights reserved.

/zigman2/quotes/201917619/composite
US : U.S.: Nasdaq
$ 3.33
+0.01 +0.30%
Volume: 1.15M
July 14, 2020 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$228.69 million
Rev. per Employee
N/A
loading...

This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.